Harrison.ai has been awarded three FDA breakthrough device designations for its imaging AI solutions, including a tool for obstructive hydrocephalus triage.
Key Details
- 1Harrison.ai received three FDA breakthrough device designations.
- 2One designation is for a triage/prioritization AI solution for obstructive hydrocephalus.
- 3The solution is among only 13% of FDA breakthrough devices to achieve 510(k) marketing authorization.
- 4It is one of only two radiology FDA breakthrough devices to become eligible for Medicare’s NTAP.
- 5The FDA program aims to speed up innovation and clinical access to critical devices.
Why It Matters
FDA breakthrough status highlights a product's potential to address unmet clinical needs, and rapid regulatory pathways can accelerate adoption in radiology practice. Harrison.ai's achievement signals growing validation and support for advanced imaging AI in critical care.
Source
Radiology Business
Related News
•AuntMinnie
AI Analyzes Chest CTs to Predict Cardiac Events Risk
A deep learning model can analyze routine chest CTs to predict major adverse cardiac event risk, outperforming traditional methods.
•AuntMinnie
Adult-Trained Radiology AI Models Struggle in Pediatric Imaging
Adult-trained radiology AI models often underperform when applied to pediatric imaging data, according to a systematic review.
•Cardiovascular Business
AI Model Dramatically Enhances Severe Heart Attack Detection via ECGs
Queen of Hearts AI model outperforms standard care in detecting severe heart attacks from ECGs.